Volume 63, Issue 1 e202315844
Research Article

Reconstitution of the Final Steps in the Biosynthesis of Valanimycin Reveals the Origin of Its Characteristic Azoxy Moiety

Ziyang Zheng

Ziyang Zheng

Department of Chemistry, University of Texas at Austin, Austin, TX-78712 USA

Search for more papers by this author
Dr. Jin Xiong

Dr. Jin Xiong

Department of Chemistry, Carnegie Mellon University, Pittsburgh, PA-15213 USA

Search for more papers by this author
Dr. Junling Bu

Dr. Junling Bu

Division of Chemical Biology and Medicinal Chemistry, College of Pharmacy, University of Texas at Austin, Austin, TX-78712 USA

Search for more papers by this author
Daan Ren

Daan Ren

Department of Chemistry, University of Texas at Austin, Austin, TX-78712 USA

Search for more papers by this author
Yu-Hsuan Lee

Yu-Hsuan Lee

Department of Chemistry, University of Texas at Austin, Austin, TX-78712 USA

Search for more papers by this author
Dr. Yu-Cheng Yeh

Dr. Yu-Cheng Yeh

Department of Chemistry, University of Texas at Austin, Austin, TX-78712 USA

Search for more papers by this author
Dr. Chia-I Lin

Dr. Chia-I Lin

Department of Chemistry, University of Texas at Austin, Austin, TX-78712 USA

Search for more papers by this author
Prof. Ronald Parry

Prof. Ronald Parry

Department of Chemistry, Rice University, Houston, TX-77005 USA

Search for more papers by this author
Prof. Yisong Guo

Prof. Yisong Guo

Department of Chemistry, Carnegie Mellon University, Pittsburgh, PA-15213 USA

Search for more papers by this author
Prof. Hung-wen Liu

Corresponding Author

Prof. Hung-wen Liu

Department of Chemistry, University of Texas at Austin, Austin, TX-78712 USA

Division of Chemical Biology and Medicinal Chemistry, College of Pharmacy, University of Texas at Austin, Austin, TX-78712 USA

Search for more papers by this author
First published: 14 November 2023
Citations: 10

Graphical Abstract

The final steps of valanimycin biosynthesis have been reconstituted in vitro. The oxidation of a dialkyl hydrazine intermediate to the characteristic azoxy moiety in valanimycin is catalyzed by VlmB, which is a non-heme diiron enzyme. The VlmB-catalyzed four-electron oxidation may commence with a resting μ-oxo diferric complex without prior reduction.

Abstract

Valanimycin is an azoxy-containing natural product isolated from the fermentation broth of Streptomyces viridifaciens MG456-hF10. While the biosynthesis of valanimycin has been partially characterized, how the azoxy group is constructed remains obscure. Herein, the membrane protein VlmO and the putative hydrazine synthetase ForJ from the formycin biosynthetic pathway are demonstrated to catalyze N−N bond formation converting O-(l-seryl)-isobutyl hydroxylamine into N-(isobutylamino)-l-serine. Subsequent installation of the azoxy group is shown to be catalyzed by the non-heme diiron enzyme VlmB in a reaction in which the N−N single bond in the VlmO/ForJ product is oxidized by four electrons to yield the azoxy group. The catalytic cycle of VlmB appears to begin with a resting μ-oxo diferric complex in VlmB, as supported by Mössbauer spectroscopy. This study also identifies N-(isobutylamino)-d-serine as an alternative substrate for VlmB leading to two azoxy regioisomers. The reactions catalyzed by the kinase VlmJ and the lyase VlmK during the final steps of valanimycin biosynthesis are established as well. The biosynthesis of valanimycin was thus fully reconstituted in vitro using the enzymes VlmO/ForJ, VlmB, VlmJ and VlmK. Importantly, the VlmB-catalyzed reaction represents the first example of enzyme-catalyzed azoxy formation and is expected to proceed by an atypical mechanism.

Conflict of interest

The authors declare no conflict of interest.

Data Availability Statement

The data that support the findings of this study are available in the supplementary material of this article.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.